HER2 interacts with nuclear factor erythroid 2-related factor 2 (NRF2) and initiates induction of NRF2 transcription, detoxification, and drug efflux proteins that confer drug resistance to cancer cells [27]. This evidence concerns the gene NFE2L2 and cancer.